Abstract
With automation and globalization come a variety of issues that affect manufacturing decisions concerning standardization, certification, and regulatory validation. The biopharmaceutical industry faces challenges related to the automation process’s unseen operational costs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
